GW Pharma (GWPH) Announces 1.7M ADS Offering

GW Pharma (NASDAQ: GWPH) announced that it and certain of its shareholders intend to sell, subject to market and other conditions, 1.7 million American Depositary Shares ("ADSs") representing ordinary shares of GW on the NASDAQ Global Market in an underwritten U.S. public offering. GW will grant the underwriters a 30-day option to purchase up to an additional 255,000 ADSs at the offering price. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The price for the offering has not yet been determined.

Morgan Stanley, BofA Merrill Lynch and Cowen and Company are acting as joint book-running managers for the offering. Piper Jaffray is acting as lead manager.

You May Also Be Interested In

• AMD (AMD) to offer senior notes in four parts
• Planet Green halted again, now up 793%
• Braveheart Bio raises $439.9M in upsized Nasdaq IPO